TGFβ, an inhibitor of endothelial cell proliferation (179), is expressed at elevated levels in myocardial hypertrophy particularly during the transition from compensated cardiac hypertrophy to heart failure (180–183). Here, TGFB1 is linked to cardiac hypertrophy.